Contribution: Industrial Research Assistance Program – Contributions to Firms
Xyon Health Inc.
$550,026.00
Business Innovation - Business Process Engineering
FY 2024-25 · 2024-08-01
Summary
This is an R&D project to test hypotheses and experiment with new mechanisms to design a repeatable and scalable business process and to develop IP in business methods.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
780995130
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-08-01 | 2024-25 | $550,026.00 |
| 1 | 2024-08-01 | 2024-25 | $550,026.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 122 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 122 jours.
Agreement End Date
2025-11-30
Agreement Number
1021656
Agreement Start Date
2024-08-01
Agreement Title
Business Innovation - Business Process Engineering
Agreement Title (French)
Innovation commerciale — Ingénierie des processus d’affaires
Agreement Type
Contribution
Agreement Value
$550,026.00
Amendment Date
2025-02-12
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This is an R&D project to test hypotheses and experiment with new mechanisms to design a repeatable and scalable business process and to develop IP in business methods.
Description (French)
Il s’agit d’un projet de R-D visant à tester des hypothèses et à expérimenter de nouveaux mécanismes afin de concevoir un processus commercial reproductible et évolutif et de développer une propriété intellectuelle en matière de méthodes commerciales.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Granville
Federal Riding (French)
Vancouver Granville
Federal Riding Number
59036
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
780995130
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Xyon Health Inc.
Recipient Postal Code
V5Y 1G3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2024-2025-Q2-1021656
